Durvalumab after chemo-radiotherapy in stage III non-small cell lung cancer

被引：4
|
作者：
Chiramel, Jaseela [1 ]
Tay, Rebecca [1 ]
Califano, Raffaele [1 ,2 ,3 ]
机构：
[1] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[2] Manchester Univ Hosp NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[3] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
PHASE-III; CONSOLIDATION CHEMOTHERAPY; RADIOTHERAPY; CONCURRENT; CISPLATIN; RADIATION; PEMBROLIZUMAB; ETOPOSIDE; TRIAL;
D O I：
10.21037/jtd.2018.04.29
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S991 / S994
页数：4
相关论文
共 50 条
  • [1] Pleural effusion in patients receiving definitive chemo-radiotherapy followed by durvalumab immunotherapy for stage III non-small cell lung cancer
    Yong, Wee Siang
    Nguyen, Thu
    Roberts-Thomson, Rachel
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 50 - 51
  • [2] Sequential Versus concurrent chemo-radiotherapy in inoperable stage III non-small cell lung cancer
    EL Sharouni, SY
    Kal, HB
    Battermann, JJ
    Schramel, FMNH
    [J]. ANTICANCER RESEARCH, 2006, 26 (1B) : 495 - 505
  • [3] Preoperative chemo-radiotherapy in stage III non-small cell lung cancer: a progress in integration of chemo-radiation
    Choi, NC
    [J]. TREATMENT OPTIMIZATION FOR LUNG CANCER: FROM CLASSICAL TO INNOVATIVE PROCEDURES, 1998, : 219 - 237
  • [4] Sequential chemo-radiotherapy in non-small cell lung cancer
    Kotas, M
    Willner, J
    Flentje, M
    [J]. LUNG CANCER, 2001, 33 : S61 - S64
  • [5] Utility of blood tests after completion of maintenance durvalumab after radical chemo-radiotherapy in patients with Non Small Cell Lung Cancer stage III
    Gil, Cano
    Vicente, Domingo
    Taher, Abu
    Milner-Watts, Charlotte
    John, Alexius
    Rehman, Faisal
    McMahon, Daivd
    Davidson, Michael
    Anna, Minchom
    Nadia, Yousaf
    Tokaca, Nadza
    Popat, Sanjay
    Bhosle, Jaishree
    O'Brien, Mary
    [J]. LUNG CANCER, 2024, 190
  • [6] Chemo-radiotherapy versus chemo-surgery in stage IIIA non-small cell lung cancer
    Stathopoulos, GP
    Papakostas, P
    Malamos, NA
    Samelis, GF
    Moschopoulos, N
    [J]. ONCOLOGY REPORTS, 1996, 3 (04) : 673 - 676
  • [7] Prognosis Impact of Oligoprogression Following Definitive Chemo-Radiotherapy in Stage III Non-Small Cell Lung Cancer
    Saigi, Maria
    Rullan, Aj
    Bergamino Sirven, Milana
    Navarro-Martin, Arturo
    Dolores Arnaiz, Ma
    Palmero, Ramon
    Plana, Maria
    Carlos Ruffinelli, Jose
    Mesia, Caries
    Padrones, Susana
    Aso, Samantha
    Brao, Isabel
    Arellano, Monica
    Saldana, Joana
    Navarro, Valentin
    Cardenal, Felipe
    Nadal, Ernest
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S851 - S852
  • [8] Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
    Tomasini, Pascale
    Greillier, Laurent
    Boyer, Arnaud
    Jeanson, Arnaud
    Barlesi, Fabrice
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S1032 - S1036
  • [9] Chemo-radiotherapy before surgery in stage III non-small-cell lung cancer
    Bonnette, P.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (02) : 105 - 114
  • [10] Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine
    Trodella, L.
    D'Angelillo, R. M.
    Ramella, S.
    Cellini, F.
    Ciresa, M.
    Cesario, A.
    Granone, P.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : V52 - V54
12345